Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    "Loiasis"
Show Display Options
Rank Status Study
1 Active, not recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine;   Other: Placebo
2 Recruiting Host Response to Infection and Treatment in Filarial Diseases
Conditions: Filariasis;   Helminthiasis;   Loiasis;   Mansonelliasis;   Onchocerciasis
3 Completed Post-Treatment Side Effects of Ivermectin or DEC for Loa Loa Infection
Condition: Loa Loa
Interventions: Drug: Diethylcarbamazine;   Drug: Ivermectin

Indicates status has not been verified in more than two years